Resource ValueSet/FHIR Server from package us.nlm.vsac#0.21.0 (79 ms)
| Package | us.nlm.vsac |
| Type | ValueSet |
| Id | Id |
| FHIR Version | R4 |
| Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1078.554/expansion |
| Url | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.554 |
| Version | 20230802 |
| Status | active |
| Date | 2023-08-02T01:13:04-04:00 |
| Name | Ditans |
| Title | Ditans |
| Experimental | False |
| Realm | us |
| Authority | hl7 |
| Purpose | (Clinical Focus: Drugs containing ditans (5-HT[1F] receptor agonists)),(Data Element Scope: DRUG_CLASS_MEMBERS: PHARMACOLOGIC:),(Inclusion Criteria: RxCUIs that are prescribable containing the following ingredient: lasmiditan),(Exclusion Criteria: Non-prescribable RxCUIs) |
Resources that use this resource
Resources that this resource uses
Source
{
"resourceType" : "ValueSet",
"id" : "2.16.840.1.113762.1.4.1078.554",
"meta" : {
"versionId" : "7",
"lastUpdated" : "2023-12-21T17:43:03.000-05:00",
"profile" : [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail" : {
"name" : "Optum Author"
}
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate" : "2023-08-02"
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate" : "2023-08-02"
}
],
"url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.554",
"identifier" : [
{
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:2.16.840.1.113762.1.4.1078.554"
}
],
"version" : "20230802",
"name" : "Ditans",
"title" : "Ditans",
"status" : "active",
"date" : "2023-08-02T01:13:04-04:00",
"publisher" : "Optum Steward",
"jurisdiction" : [
{
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "US"
}
]
}
],
"purpose" : "(Clinical Focus: Drugs containing ditans (5-HT[1F] receptor agonists)),(Data Element Scope: DRUG_CLASS_MEMBERS: PHARMACOLOGIC:),(Inclusion Criteria: RxCUIs that are prescribable containing the following ingredient: lasmiditan),(Exclusion Criteria: Non-prescribable RxCUIs)",
"compose" : {
"include" : [
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"concept" : [
{
"code" : "2256930",
"display" : "lasmiditan"
},
{
"code" : "2256933",
"display" : "lasmiditan 100 MG"
},
{
"code" : "2256934",
"display" : "lasmiditan Oral Product"
},
{
"code" : "2256935",
"display" : "lasmiditan Pill"
},
{
"code" : "2256936",
"display" : "lasmiditan Oral Tablet"
},
{
"code" : "2256937",
"display" : "lasmiditan 100 MG Oral Tablet"
},
{
"code" : "2256938",
"display" : "Reyvow"
},
{
"code" : "2256939",
"display" : "lasmiditan 100 MG [Reyvow]"
},
{
"code" : "2256940",
"display" : "lasmiditan Oral Tablet [Reyvow]"
},
{
"code" : "2256941",
"display" : "Reyvow Oral Product"
},
{
"code" : "2256942",
"display" : "Reyvow Pill"
},
{
"code" : "2256943",
"display" : "lasmiditan 100 MG Oral Tablet [Reyvow]"
},
{
"code" : "2256944",
"display" : "lasmiditan 50 MG"
},
{
"code" : "2256945",
"display" : "lasmiditan 50 MG Oral Tablet"
},
{
"code" : "2256946",
"display" : "lasmiditan 50 MG [Reyvow]"
},
{
"code" : "2256947",
"display" : "lasmiditan 50 MG Oral Tablet [Reyvow]"
}
]
}
]
},
"expansion" : {
"identifier" : "urn:uuid:4332133e-07eb-48c3-bec2-8b24b77f0ab3",
"timestamp" : "2024-12-10T05:40:59-05:00",
"total" : 16,
"contains" : [
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2256930",
"display" : "lasmiditan"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2256933",
"display" : "lasmiditan 100 MG"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2256934",
"display" : "lasmiditan Oral Product"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2256935",
"display" : "lasmiditan Pill"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2256936",
"display" : "lasmiditan Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2256937",
"display" : "lasmiditan 100 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2256938",
"display" : "Reyvow"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2256939",
"display" : "lasmiditan 100 MG [Reyvow]"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2256940",
"display" : "lasmiditan Oral Tablet [Reyvow]"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2256941",
"display" : "Reyvow Oral Product"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2256942",
"display" : "Reyvow Pill"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2256943",
"display" : "lasmiditan 100 MG Oral Tablet [Reyvow]"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2256944",
"display" : "lasmiditan 50 MG"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2256945",
"display" : "lasmiditan 50 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2256946",
"display" : "lasmiditan 50 MG [Reyvow]"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2256947",
"display" : "lasmiditan 50 MG Oral Tablet [Reyvow]"
}
]
},
"text" : {
}
}
XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.
FHIR